Published in Neurology on March 12, 2002
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol (2006) 2.06
Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. J Clin Invest (2005) 1.41
The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. Handb Clin Neurol (2014) 1.11
MicroRNAs and Multiple Sclerosis. Autoimmune Dis (2010) 0.94
Measles IgG antibody index correlates with T2 lesion load on MRI in patients with early multiple sclerosis. PLoS One (2012) 0.92
A multifactorial prognostic index in multiple sclerosis. Cerebrospinal fluid IgM oligoclonal bands and clinical features to predict the evolution of the disease. J Neurol (2008) 0.84
Intrathecal IgM production at clinical onset correlates with a more severe disease course in multiple sclerosis. J Neurol Neurosurg Psychiatry (2006) 0.82
MRI criteria in MS patients with negative and positive oligoclonal bands: equal fulfillment of Barkhof's criteria but different lesion patterns. J Neurol (2009) 0.79
Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management. Ther Adv Neurol Disord (2016) 0.75
Primary progressive multiple sclerosis and generalized myasthenia gravis: an uncommon association. Neurol Sci (2010) 0.75
Results of radical resection for periampullary cancer. Ann Surg (1975) 2.12
Guidelines for the treatment of acute ischaemic stroke. Neurologia (2011) 2.05
[Weight-loss drugs: composition of diet pills prescribed in Navarra]. An Med Interna (1997) 2.05
Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus (2008) 2.00
Clinically isolated syndromes: a new oligoclonal band test accurately predicts conversion to MS. Neurology (2006) 1.46
Off-label intravenous thrombolysis in acute stroke. Eur J Neurol (2011) 1.44
Intestinal intraepithelial lymphocytes contain a CD3- CD7+ subset expressing natural killer markers and a singular pattern of adhesion molecules. Scand J Immunol (2000) 1.11
Essential role of tumor necrosis factor-alpha in the differentiation of human tonsil in vivo induced B cells capable of spontaneous and high-rate immunoglobulin secretion. Eur J Immunol (1993) 1.10
Disorders of regulatory T cells in patients with selective IgA deficiency and its relationship to associated autoimmune phenomena. Clin Exp Immunol (1982) 1.09
Interleukin-6 dimers produced by endothelial cells inhibit apoptosis of B-chronic lymphocytic leukemia cells. Blood (2001) 1.02
Role of tumor necrosis factor-alpha in the pathogenesis of glomerular diseases. Kidney Int Suppl (1993) 1.01
Foetal sex determination in maternal blood from the seventh week of gestation and its role in diagnosing haemophilia in the foetuses of female carriers. Haemophilia (2008) 0.99
HLA antigens in a sample of the Spanish population: common features among Spaniards, Basques, and Sardinians. Hum Genet (1981) 0.97
Familial C1q deficiency associated with renal and cutaneous disease. Clin Exp Immunol (1981) 0.97
Flow cytometry description of a novel CD3-/CD7+ intraepithelial lymphocyte subset in human duodenal biopsies: potential diagnostic value in coeliac disease. Cytometry (1998) 0.96
In-hospital stroke: a multi-centre prospective registry. Eur J Neurol (2011) 0.96
Lithium-induced headache. Headache (1989) 0.95
Normal and clonal B lineage cells can be distinguished by their differential expression of B cell antigens and adhesion molecules in peripheral blood from multiple myeloma (MM) patients--diagnostic and clinical implications. Clin Exp Immunol (1998) 0.95
[Cerebral venous thrombosis: when etiology makes the difference]. Neurologia (2009) 0.94
Anti-transglutaminase IgA ELISA: clinical potential and drawbacks in celiac disease diagnosis. Scand J Gastroenterol (2001) 0.92
Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch Biochem Biophys (1998) 0.91
[Recommendations for using and interpreting magnetic resonance imaging in multiple sclerosis]. Neurologia (2010) 0.91
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS. Neurology (2002) 0.91
Detection of soluble class I molecules (non HLA-A or HLA-B) in serum, spleen membranes and lymphocytes in culture. Eur J Immunol (1989) 0.90
Use of the ELISA to detect and quantify histocompatibility antigens and their subunits. J Immunol Methods (1983) 0.90
Soluble HLA class I antigen secretion by normal lymphocytes: relationship with cell activation and effect of interferon-gamma. Clin Exp Immunol (1990) 0.90
Hepatocyte damage induced by lymphocytes from patients with chronic liver diseases, as detected by LDH release. Clin Exp Immunol (1978) 0.90
Immunological findings in immunoblastic lymphadenopathy. A detailed case study. Clin Exp Immunol (1977) 0.88
Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type. Neurologia (2011) 0.88
Identification of feto-maternal haemorrhage around labour using flow cytometry immunophenotyping. Eur J Obstet Gynecol Reprod Biol (2010) 0.88
Diffuse plasma cell infiltration of the small intestine with malabsorption associated to IgA monoclonal gammapathy. Cancer (1974) 0.88
B cell hyperactivity and abnormalities in T cell markers and immunoregulatory function in a patient with nucleoside phosphorylase deficiency. Clin Exp Immunol (1982) 0.87
A sensitive and reproducible method for the detection of oligoclonal IgM bands. J Immunol Methods (2001) 0.87
Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands. Mult Scler (2010) 0.86
Multiple sclerosis patients with anti-lipid oligoclonal IgM show early favourable response to immunomodulatory treatment. Eur J Neurol (2009) 0.86
Clinical practice guidelines in intracerebral haemorrhage. Neurologia (2011) 0.86
Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease. Neurology (1998) 0.85
Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment. Hematol J (2000) 0.85
Lumphocytotoxins in leprosy. Int J Lepr Other Mycobact Dis (1976) 0.85
Quantification of soluble serum HLA class I antigens in healthy volunteers and AIDS patients. Clin Chim Acta (1988) 0.85
Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration. Clin Exp Immunol (1985) 0.85
Efficacy of intravenous thrombolysis according to stroke subtypes: the Madrid Stroke Network data. Eur J Neurol (2012) 0.85
Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis. Mult Scler (2008) 0.85
Influence of oligoclonal IgM specificity in multiple sclerosis disease course. Mult Scler (2007) 0.85
Botulism with sensory symptoms: a second case. J Neurol Neurosurg Psychiatry (1991) 0.85
Interferon beta-1b treatment in patients with relapsing--remitting multiple sclerosis under a standardized protocol in Spain. Acta Neurol Scand (2000) 0.84
Hereditary angio-oedema with mesangiocapillary glomerulonephritis. Postgrad Med J (1977) 0.84
The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands. J Neuroimmunol (2010) 0.84
Increased levels of IL-15 mRNA in relapsing--remitting multiple sclerosis attacks. J Neuroimmunol (2002) 0.84
Natural killer cell subsets in cerebrospinal fluid of patients with multiple sclerosis. Clin Exp Immunol (2015) 0.83
Disorders of regulatory T cell function in patients with the Wiskott-Aldrich syndrome. Clin Exp Immunol (1984) 0.83
Human in vivo-induced spontaneous IgG-secreting cells from tonsil, blood and bone marrow exhibit different phenotype and functional level of maturation. Immunology (1991) 0.83
HLA factors in non-insulin-dependent diabetes mellitus. N Engl J Med (1980) 0.83
Biomechanical effects of the full range of useful doses of (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) on femur diaphyses and cortical bone tissue in rats. Bone Miner (1990) 0.83
Studies on the quaternary structure of class I major histocompatibility complex antigens. Effect of different agents on the interaction between subunits. J Biol Chem (1986) 0.82
Functional assessment of T and B lymphocytes in patients with selective IgM deficiency. Clin Exp Immunol (1982) 0.82
The costs of stroke in Spain by aetiology: the CONOCES study protocol. Neurologia (2012) 0.82
EEG patterns suggestive of shifted levels of excitation effected by hathayogic exercises. Act Nerv Super (Praha) (1985) 0.81
Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis. J Neuroimmunol (2000) 0.81
Fluorocytometric analysis of induced sputum cells in an asthmatic population. J Investig Allergol Clin Immunol (2004) 0.81
[Cerebellar syndrome and myoclonus in a patient with adenocarcinoma of the colon]. Rev Neurol (2000) 0.81
Reverse enzyme immunoassay for the determination of Dermatophagoides pteronyssinus IgE antibodies. Int Arch Allergy Appl Immunol (1983) 0.81
SHP-1 expression in peripheral T cells from patients with Sezary syndrome and in the T cell line HUT-78: implications in JAK3-mediated signaling. Leukemia (2002) 0.81
Cranial computed tomography in pediatric migraine. Pediatr Radiol (1984) 0.81
Significance of the volume of fetomaternal hemorrhage after performing prenatal invasive tests. Cytometry B Clin Cytom (2011) 0.81
Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus. Ann Rheum Dis (2007) 0.81
Purification and properties of membrane and cytosolic phosphatidylinositol-specific phospholipases C from human spleen. J Biol Chem (1991) 0.81
Cancer after renal transplantation. Transplant Proc (2003) 0.80
Induction of apoptosis by cerebrospinal fluid from patients with primary-progressive multiple sclerosis in cultured neurons. Neurosci Lett (1998) 0.80
Increased levels of plasma von Willebrand factor in migraine crisis. Acta Neurol Scand (1995) 0.80
Soluble class 1 antigens (sHLA) in CSF and serum of patients with HIV infection. Acta Neurol Scand (1990) 0.80
Intrathecal synthesis of soluble class I antigens in multiple sclerosis. J Neuroimmunol (1992) 0.80
Limitations of anti-guinea pig liver transglutaminase IgA in screening of celiac disease. Gastroenterology (2001) 0.80
Caspase inhibitors protect against neuronal apoptosis induced by cerebrospinal fluid from multiple sclerosis patients. J Neuroimmunol (2003) 0.80
Lauryl gallate inhibits the activity of protein tyrosine kinase c-Src purified from human platelets. J Enzyme Inhib (2001) 0.80